TheEdgeResearch
Home / Stocks / BWAY

BrainsWay Ltd. (BWAY)

NASDAQ Healthcare Medical - Specialties
$8.48 ▼ -2.86%
Market Cap
$332.6M
Sector
Healthcare
Industry
Medical - Specialties
Beta
0.15
52-Wk Range
7.3-17.4
CEO
Hadar Levy
Country
IL
Currency
USD

BrainsWay Ltd. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Jerusalem, JM, IL. The stock last traded at $8.48, down 2.86% on the session, giving a market capitalisation of $332.6M. On trailing twelve-month figures it carries a trailing P/E of 34.45, a net margin of 14.6%. Its beta of 0.15 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
34.45
Price / Sales
5.15
Price / Book
4.33
EV / EBITDA
43.43
Gross margin
76.0%
Operating margin
13.3%
Net margin
14.6%
Return on equity
—
Debt / equity
0.08
Current ratio
2.89
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
129
IPO date
2019-04-17
Headquarters
Jerusalem, JM, IL
About BrainsWay Ltd.

Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally in creating and distributing advanced, non-invasive neurostimulation therapies designed to address a wide array of mental health and neurological conditions. The company's primary innovation is its Deep Transcranial Magnetic Stimulation (dTMS) platform, which offers treatment for disorders including major and anxious depression, obsessive-compulsive disorder, nicotine addiction, bipolar disorder, post-traumatic stress disorder, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's solutions are primarily adopted by psychiatric practitioners, hospitals, and medical centers across the United States, Europe, Israel, and other international markets.

Comparable companies

BrainsWay Ltd. is most often compared with the following Healthcare names:

HSDTMOBINPCENXLSTIM
More research on BWAY
BWAY technical analysis BWAY TheEdge Score Compare against peers
Open full interactive analysis & DCF →